Vaccine Contract Manufacturing Market Report 2016-2026

Jan 06, 2016, 09:00 ET from Visiongain

LONDON, January 5, 2016 /PRNewswire/ --

Leading Countries, Technologies and Companies

What can be expected from the vaccine contract manufacturing market? Which areas are going to grow at the fastest rates? This visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects there.

Our 148-page report provides 76 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2016-2026 and other analyses show you commercial prospects 

Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analysis and commercial developments.

See revenue forecasts for the leading international markets 

How will leading national markets perform to 2026? Our study forecasts revenues in national markets including products, including:
• US
• UK

Leading companies and potential for market growth 

Overall revenue for the vaccine contract manufacturing market will reach $1047.3m in 2019, our work forecasts. We predict good revenue growth through to 2026.

To see a report overview please email Sara Peerun on

Increasing demands for therapeutic vaccines and an ageing population will help drive the market for vaccines over the forecast period, which in turn helps drive the vaccine contract manufacturing business.

Our work analyses the key companies in the market. See visiongain's analysis of leading companies, including these:
• Baxter BioPharma Solutions
• Boehringer Ingelheim
• Catalent
• Charles River Laboratories
• IDT Biologika
• Lonza
• Meridian Life Science
• Sigma Aldrich Fine Chemical (Merck)
• Synco Bio Partners

A company profile gives you the following information where available:
• Discussion of a company's activities and outlook
• Company news relevant to the market

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What issues will affect Vaccine contract manufacturing industry? 

Our new report discusses issues and events affecting the vaccine contract manufacturing market. You will find discussions, including qualitative analyses:
• The emergence of developing markets as manufacturing centres
• Increasing potential in both established and emerging markets

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Vaccine Contract Manufacturing Market 2016-2026 report helps you 

In summary, our 148-page report gives you the following knowledge:
• Revenue forecasts to 2026 for the vaccine contract manufacturing market - discover the industry's prospects, finding promising places for investments and revenues
• Revenue forecasts to 2026 for the leading national markets - US, Japan, EU5 (Germany, UK, France, Italy and Spain), China, India, Brazil and Russia
• Assessment of leading companies - analysis of vaccine manufacturing capabilities, revenue and news (Baxter BioPharma Solutions, Boehringer Ingelheim, Catalent, Charles River Laboratories, IDT Biologika, Lonza, Meridian Life Science, Sigma Aldrich Fine Chemical (Merck), Synco Bio Partners)
• Discussion of what stimulates and restrains companies and the market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the vaccine contract manufacturing market and leading companies. You will find data, trends and predictions. Please order our report now.

To see a report overview please email Sara Peerun on

To request an exec summary of this report please email Sara Peerun at or call Tel: +44-(0)20-7336-6100

Or click on

Companies Listed
Aeras Global
ATM Life Sciences
AVEO Pharmaceuticals
Balian Hissen Bio-Pharm
Baxter BioPharma Solutions
Beijing Tiantan Biological Productions
Berna Biotech
Bharat Biotech International Limited
Boehringer Ingelheim Biopharmaceuticals (China)
Cadila Pharmaceuticals
Cellexus Limitied
CSL Biotherapies
Daiichi Sankyo
GE Healthcare
Hualan Biological Bacterin
Intercell Corporation
Irvine Scientific
LG Life Sciences
Meissner Filtration
Merck Serono
Micron Technologies
Mitsubishi Tanabe Pharma (MTPC)
MP Biomedicals
Organon Teknika Corporation
Pall Life Sciences
Paragon Bioservices
PBS Biotech
Philip Morris Investments
Pierre-Guerin Biolafitte
Protein Sciences Corporation
Refine Technology
Sartorius Stedim
Shanghai Zhangjiang Biotech and Pharmaceutical Base Development Co. Ltd.
Sigma Aldrich
Thermo Fisher
Vector Solutions
Wave Biotech
Wyeth Pharmaceuticals


Organisations Mentioned in the Report
Biomedical Advanced Research and Development Authority (BARDA)
Center for Disease Control (CDC)
China Food and Drug Administration (CFDA)
Defense Advanced Research Projects Agency (DARPA)
Food and Drug Administration (FDA)
Insitut Pasteur
National Institute of Allergy and Infectious Diseases (NIAID)
U.S Department of Homeland Security
U.S. Department of Health and Human Services Office
World Health Organisation (WHO)

To see a report overview please email Sara Peerun on

SOURCE Visiongain